Tetravalent Dengue Vaccine Reduces Symptomatic and Asymptomatic Dengue Virus Infections in Healthy Children and Adolescents Aged 2–16 Years in Asia and Latin America

por Olivera-Botello, Gustavo, Coudeville, Laurent, Fanouillere, Karen, Guy, Bruno, Chambonneau, Laurent, Noriega, Fernando, Jackson, Nicholas
Publicado 2016

Dengue seroprevalence: data from the clinical development of a tetravalent dengue vaccine in 14 countries (2005–2014)

por L’Azou, Maïna, Assoukpa, Jade, Fanouillere, Karen, Plennevaux, Eric, Bonaparte, Matthew, Bouckenooghe, Alain, Frago, Carina, Noriega, Fernando, Zambrano, Betzana, Ochiai, R Leon, Guy, Bruno, Jackson, Nicholas
Publicado 2018